|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07K 16/28 | (2006.01) |
| C07K 16/30 | (2006.01) | ||
| C07K 16/32 | (2006.01) |
| (11) | Number of the document | 2896632 |
| (13) | Kind of document | T |
| (96) | European patent application number | 15154165.3 |
| Date of filing the European patent application | 2010-11-12 | |
| (97) | Date of publication of the European application | 2015-07-22 |
| (45) | Date of publication and mention of the grant of the patent | 2017-10-25 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 261149 P | 2009-11-13 | US |
| (72) |
Hettmann, Thore, BE
Freeman, Daniel, J., US
Radinsky, Robert, US
|
| (73) |
Amgen Inc.,
One Amgen Center Drive, Thousand Oaks, California 91320-1799,
US
Daiichi Sankyo Europe GmbH, Zielstattstr. 48, 81379 München, DE |
| (54) | Material and methods for treating or preventing HER-3 associated diseases |
| Material and methods for treating or preventing HER-3 associated diseases |